CHARLES WYKOFF

Concepts (522)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Diabetic Retinopathy
78
2025
165
22.920
Why?
Angiogenesis Inhibitors
103
2025
219
19.400
Why?
Macular Edema
57
2025
98
15.670
Why?
Visual Acuity
110
2025
843
14.030
Why?
Wet Macular Degeneration
36
2025
45
10.850
Why?
Macular Degeneration
33
2025
128
10.510
Why?
Ranibizumab
61
2025
75
10.510
Why?
Vascular Endothelial Growth Factor A
89
2025
444
10.080
Why?
Receptors, Vascular Endothelial Growth Factor
51
2024
99
9.480
Why?
Intravitreal Injections
101
2025
154
9.400
Why?
Tomography, Optical Coherence
90
2025
568
8.740
Why?
Recombinant Fusion Proteins
52
2025
795
8.730
Why?
Geographic Atrophy
17
2025
26
7.500
Why?
Fluorescein Angiography
68
2025
152
7.380
Why?
Macula Lutea
18
2025
50
5.100
Why?
Retinal Diseases
18
2024
179
4.900
Why?
Retinal Detachment
16
2025
86
4.750
Why?
Diabetes Mellitus
19
2024
931
4.670
Why?
Vitrectomy
26
2025
111
4.610
Why?
Antibodies, Monoclonal, Humanized
23
2024
555
4.390
Why?
Retinal Vein Occlusion
17
2022
28
4.380
Why?
Retinal Vessels
24
2024
77
4.360
Why?
Choroidal Neovascularization
12
2023
35
4.240
Why?
Retinal Perforations
10
2024
27
3.680
Why?
Laser Coagulation
17
2023
130
3.550
Why?
Bevacizumab
20
2024
78
2.930
Why?
Retina
22
2023
498
2.530
Why?
Humans
249
2025
133589
2.160
Why?
Aged
97
2025
21699
2.140
Why?
Scleral Buckling
9
2022
14
2.120
Why?
Choroid
8
2024
42
2.090
Why?
Glucocorticoids
10
2024
408
2.040
Why?
Middle Aged
104
2025
29349
2.010
Why?
Endophthalmitis
7
2016
78
2.000
Why?
Follow-Up Studies
42
2025
5491
1.910
Why?
Aged, 80 and over
49
2025
7203
1.790
Why?
Fundus Oculi
20
2025
66
1.710
Why?
Prospective Studies
48
2025
6650
1.700
Why?
Male
123
2025
65783
1.620
Why?
Treatment Outcome
58
2025
13003
1.610
Why?
Photography
6
2022
101
1.610
Why?
Female
128
2025
71528
1.570
Why?
Peptides, Cyclic
2
2023
57
1.550
Why?
Ischemia
10
2021
383
1.470
Why?
Vitreous Detachment
3
2024
15
1.320
Why?
Retrospective Studies
58
2025
17437
1.320
Why?
Complement Inactivating Agents
4
2023
12
1.310
Why?
Complement C3
4
2023
54
1.260
Why?
Fovea Centralis
4
2020
10
1.170
Why?
Endothelial Growth Factors
12
2023
53
1.170
Why?
Eye Infections, Bacterial
3
2016
92
1.140
Why?
Retinal Vasculitis
4
2023
9
1.130
Why?
Triamcinolone Acetonide
4
2024
37
1.110
Why?
Retinal Pigment Epithelium
5
2024
37
1.110
Why?
Subretinal Fluid
7
2024
11
1.060
Why?
Double-Blind Method
16
2025
1669
1.060
Why?
Nerve Fibers
3
2025
76
0.990
Why?
Retinal Telangiectasis
3
2025
5
0.990
Why?
Epiretinal Membrane
4
2024
15
0.970
Why?
Adult
52
2025
31933
0.940
Why?
Peripherins
1
2024
2
0.940
Why?
Disease Progression
14
2025
2238
0.890
Why?
Fluocinolone Acetonide
4
2020
7
0.890
Why?
Vitreous Body
5
2024
106
0.850
Why?
ATP-Binding Cassette Transporters
1
2024
196
0.840
Why?
Cysts
2
2024
108
0.840
Why?
Retinal Vein
3
2022
12
0.820
Why?
Ophthalmology
6
2024
200
0.820
Why?
Drug Delivery Systems
3
2025
233
0.800
Why?
Angiopoietin-2
4
2024
16
0.800
Why?
Cataract
3
2022
227
0.790
Why?
Clinical Trials as Topic
5
2023
1153
0.790
Why?
Benchmarking
1
2023
148
0.780
Why?
Eye Infections, Fungal
4
2014
78
0.770
Why?
Antibodies, Bispecific
2
2024
51
0.770
Why?
Edema
2
2022
141
0.740
Why?
Carbonic Anhydrases
11
2003
26
0.720
Why?
Neovascularization, Pathologic
7
2018
258
0.710
Why?
Ophthalmic Solutions
2
2011
93
0.710
Why?
Ophthalmoscopy
3
2019
29
0.700
Why?
Vision Disorders
4
2023
220
0.680
Why?
No-Show Patients
1
2020
3
0.680
Why?
Basement Membrane
5
2024
49
0.670
Why?
Vitreoretinal Surgery
2
2021
7
0.670
Why?
Lost to Follow-Up
1
2020
33
0.660
Why?
Retinal Hemorrhage
2
2017
26
0.660
Why?
Cataract Extraction
3
2017
221
0.650
Why?
Sensory Thresholds
1
2019
37
0.640
Why?
Patient Dropouts
1
2019
53
0.640
Why?
Anti-Inflammatory Agents
2
2019
324
0.630
Why?
Postoperative Complications
4
2017
3208
0.620
Why?
Choroid Diseases
1
2019
23
0.610
Why?
Time Factors
12
2025
6582
0.610
Why?
Eye Diseases
2
2011
118
0.610
Why?
Microaneurysm
3
2023
3
0.580
Why?
Monitoring, Physiologic
1
2020
387
0.570
Why?
Retinal Degeneration
3
2025
104
0.550
Why?
Lasers
2
2017
117
0.530
Why?
Patient Compliance
1
2019
480
0.510
Why?
Drug Administration Schedule
6
2022
755
0.510
Why?
Biomarkers
11
2025
3411
0.500
Why?
Lasers, Solid-State
1
2016
19
0.500
Why?
Meningoencephalitis
1
2016
21
0.500
Why?
Retinitis
1
2016
18
0.500
Why?
Randomized Controlled Trials as Topic
7
2024
1195
0.470
Why?
Anti-Bacterial Agents
5
2019
2511
0.470
Why?
Antibiotic Prophylaxis
1
2016
128
0.470
Why?
Silicone Oils
2
2025
13
0.470
Why?
Vancomycin
1
2017
236
0.450
Why?
Waldenstrom Macroglobulinemia
1
2018
154
0.450
Why?
Cell Hypoxia
12
2004
104
0.450
Why?
Povidone-Iodine
2
2011
10
0.450
Why?
Clinical Protocols
5
2022
244
0.450
Why?
Mutation
3
2025
6276
0.450
Why?
Injections, Intraocular
3
2024
11
0.440
Why?
West Nile Fever
1
2016
139
0.430
Why?
Cryosurgery
1
2013
48
0.420
Why?
Fungi
3
2014
76
0.410
Why?
Retinal Ganglion Cells
2
2025
115
0.410
Why?
Carcinoma, Renal Cell
4
2004
251
0.410
Why?
Precision Medicine
2
2018
358
0.410
Why?
Atrophy
6
2024
250
0.400
Why?
Uveitis
2
2024
38
0.400
Why?
Choroid Neoplasms
2
2013
26
0.390
Why?
Vitreoretinopathy, Proliferative
2
2022
7
0.390
Why?
Transcription Factors
10
2004
2704
0.380
Why?
Nuclear Proteins
9
2004
1334
0.380
Why?
Antisepsis
1
2011
7
0.380
Why?
Mycoses
2
2014
121
0.370
Why?
Ophthalmologists
2
2024
17
0.370
Why?
Eye
2
2024
233
0.370
Why?
Ciliary Body
1
2011
32
0.360
Why?
Bacteria
2
2016
537
0.360
Why?
Retinal Neovascularization
3
2020
16
0.360
Why?
Young Adult
9
2025
9897
0.360
Why?
Surgical Wound Infection
2
2017
276
0.350
Why?
Ubiquitin-Protein Ligases
3
2004
384
0.350
Why?
Kidney Neoplasms
4
2004
460
0.350
Why?
Endotamponade
3
2025
11
0.350
Why?
Retinitis Pigmentosa
2
2025
93
0.350
Why?
Tumor Suppressor Proteins
3
2004
510
0.350
Why?
Uveal Neoplasms
1
2011
61
0.350
Why?
Retreatment
4
2018
92
0.350
Why?
Algorithms
6
2024
1730
0.340
Why?
Retinal Drusen
3
2024
6
0.340
Why?
Aging
1
2018
1303
0.340
Why?
Regression Analysis
3
2022
832
0.340
Why?
Diagnosis, Differential
3
2024
1967
0.340
Why?
Hospitals, University
1
2010
104
0.340
Why?
Surgical Flaps
2
2024
212
0.330
Why?
Antibodies, Monoclonal
3
2019
1070
0.330
Why?
Cephalosporins
1
2011
143
0.330
Why?
Neoplasm Proteins
10
2004
717
0.330
Why?
Regional Blood Flow
3
2019
226
0.320
Why?
Drug Hypersensitivity
1
2011
102
0.320
Why?
Pharmaceutical Preparations
3
2023
90
0.320
Why?
Monitoring, Intraoperative
1
2010
134
0.310
Why?
Cryptococcosis
1
2009
44
0.310
Why?
Quality of Life
4
2023
2127
0.310
Why?
Oculomotor Nerve
1
2008
6
0.300
Why?
DNA-Binding Proteins
8
2004
2159
0.300
Why?
Cranial Nerve Neoplasms
1
2008
8
0.300
Why?
Capillary Permeability
2
2020
77
0.300
Why?
Drug Therapy, Combination
4
2025
1200
0.300
Why?
Oculomotor Nerve Diseases
1
2008
17
0.300
Why?
Blindness
2
2021
79
0.300
Why?
Eye Injuries, Penetrating
1
2008
19
0.300
Why?
Risk Factors
11
2024
11054
0.290
Why?
Exudates and Transudates
2
2021
22
0.290
Why?
Rhabdoid Tumor
1
2008
56
0.290
Why?
Adolescent
7
2024
20512
0.290
Why?
Antigens, Neoplasm
8
2003
407
0.280
Why?
Corneal Ulcer
1
2008
57
0.280
Why?
Combined Modality Therapy
8
2020
1314
0.280
Why?
Vitelliform Macular Dystrophy
2
2024
2
0.280
Why?
Single-Blind Method
2
2021
251
0.270
Why?
Teratoma
1
2008
130
0.270
Why?
Cross Infection
1
2010
331
0.270
Why?
Practice Guidelines as Topic
3
2024
1333
0.260
Why?
Gene Expression Regulation, Neoplastic
4
2002
2117
0.250
Why?
Severity of Illness Index
5
2021
3067
0.240
Why?
Hexokinase
1
2025
23
0.240
Why?
Gene Expression Profiling
2
2004
1911
0.230
Why?
Cross-Sectional Studies
7
2024
3739
0.230
Why?
United States
9
2024
11654
0.230
Why?
Biomarkers, Tumor
7
2008
1716
0.230
Why?
Intraocular Pressure
2
2024
146
0.230
Why?
Melanoma
2
2013
976
0.230
Why?
Aqueous Humor
2
2022
28
0.220
Why?
Oxygen
6
2018
577
0.220
Why?
Keratomileusis, Laser In Situ
1
2006
149
0.220
Why?
Angiopoietins
2
2021
21
0.220
Why?
Drug Approval
1
2024
45
0.220
Why?
Myopia
1
2006
194
0.220
Why?
Complement C5
1
2023
7
0.220
Why?
Cross-Over Studies
1
2025
331
0.220
Why?
Carcinoma, Intraductal, Noninfiltrating
2
2002
73
0.220
Why?
Ligases
2
2000
48
0.220
Why?
Cyclin D1
1
2004
123
0.220
Why?
Hypoxia
4
2004
262
0.220
Why?
Tumor Cells, Cultured
9
2004
1101
0.210
Why?
Entropy
1
2023
29
0.210
Why?
United States Food and Drug Administration
1
2024
158
0.210
Why?
Meta-Analysis as Topic
1
2024
172
0.210
Why?
Biosimilar Pharmaceuticals
1
2023
6
0.210
Why?
Photochemotherapy
2
2022
48
0.210
Why?
Aptamers, Nucleotide
1
2023
33
0.210
Why?
Drainage
1
2025
265
0.210
Why?
Evidence-Based Medicine
2
2024
667
0.210
Why?
Traction
1
2022
9
0.200
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
9
2004
104
0.200
Why?
Drug Resistance
2
2013
263
0.200
Why?
Eye Neoplasms
2
2013
52
0.200
Why?
Prone Position
1
2022
33
0.190
Why?
Central Serous Chorioretinopathy
1
2022
6
0.190
Why?
Hypoxia-Inducible Factor 1
8
2004
19
0.190
Why?
Porphyrins
1
2022
18
0.190
Why?
Delphi Technique
1
2023
243
0.190
Why?
Polyethylene Glycols
1
2023
251
0.190
Why?
Imaging, Three-Dimensional
1
2024
396
0.190
Why?
Biomedical Research
2
2019
555
0.190
Why?
Equipment Design
2
2020
611
0.180
Why?
Carcinoma, Non-Small-Cell Lung
4
2012
383
0.180
Why?
Confidence Intervals
1
2021
301
0.180
Why?
Postoperative Period
2
2020
348
0.180
Why?
Blood-Retinal Barrier
2
2020
3
0.180
Why?
Drug Implants
2
2020
44
0.180
Why?
Computer Systems
1
2021
38
0.180
Why?
Cornea
1
2006
681
0.170
Why?
Registries
3
2023
1557
0.170
Why?
Dose-Response Relationship, Drug
4
2020
1734
0.170
Why?
Videoconferencing
1
2020
22
0.170
Why?
Cytokines
3
2022
1397
0.170
Why?
Surgery, Computer-Assisted
2
2020
65
0.170
Why?
Patient Reported Outcome Measures
1
2022
203
0.160
Why?
Fractals
1
2019
2
0.160
Why?
Receptor, Platelet-Derived Growth Factor beta
1
2019
20
0.160
Why?
Consensus
1
2023
732
0.160
Why?
Microcirculation
2
2019
118
0.160
Why?
Recurrence
3
2019
1470
0.160
Why?
Income
1
2020
141
0.160
Why?
Congresses as Topic
1
2020
187
0.160
Why?
Biological Products
1
2021
140
0.150
Why?
Insurance Coverage
1
2020
124
0.150
Why?
Early Diagnosis
1
2019
199
0.150
Why?
Longitudinal Studies
2
2022
1485
0.150
Why?
Delayed-Action Preparations
1
2018
122
0.150
Why?
Antifungal Agents
3
2014
309
0.150
Why?
Continuity of Patient Care
1
2020
154
0.150
Why?
Cost-Benefit Analysis
1
2021
565
0.150
Why?
Necrosis
7
2004
221
0.140
Why?
Vision, Low
1
2017
14
0.140
Why?
Visual Prosthesis
1
2017
6
0.140
Why?
Diagnostic Techniques, Ophthalmological
1
2019
103
0.140
Why?
Proteins
2
2000
1088
0.140
Why?
Ultrasonography
3
2024
992
0.140
Why?
Breast Neoplasms
5
2004
2769
0.140
Why?
Betacoronavirus
1
2020
309
0.130
Why?
Drug and Narcotic Control
1
2016
17
0.130
Why?
Legislation, Drug
1
2016
9
0.130
Why?
Prosthesis Implantation
1
2017
146
0.130
Why?
Beryllium
1
2016
3
0.130
Why?
Administration, Topical
1
2016
143
0.130
Why?
Cohort Studies
6
2022
5180
0.120
Why?
Genes, Tumor Suppressor
3
2002
225
0.120
Why?
Therapeutic Equivalency
1
2015
13
0.120
Why?
Patient Acceptance of Health Care
1
2020
471
0.120
Why?
Photoreceptor Cells, Vertebrate
1
2015
41
0.120
Why?
Coronavirus Infections
1
2020
388
0.120
Why?
Pneumonia, Viral
1
2020
399
0.110
Why?
Lung Neoplasms
4
2012
1796
0.110
Why?
Medication Adherence
1
2018
339
0.110
Why?
Vascular Endothelial Growth Factors
3
2023
53
0.110
Why?
Von Hippel-Lindau Tumor Suppressor Protein
3
2004
37
0.110
Why?
Fluconazole
2
2014
50
0.110
Why?
Amphotericin B
2
2014
93
0.110
Why?
von Hippel-Lindau Disease
3
2002
20
0.100
Why?
History, 18th Century
1
2013
70
0.100
Why?
Practice Patterns, Physicians'
1
2019
766
0.100
Why?
Electronic Health Records
1
2020
790
0.100
Why?
Carbonic Anhydrase IX
8
2003
13
0.100
Why?
Observational Studies as Topic
2
2023
102
0.100
Why?
Anterior Chamber
1
2012
58
0.090
Why?
Electroretinography
2
2025
123
0.090
Why?
Chlorhexidine
1
2011
47
0.090
Why?
Blood Glucose
1
2016
1194
0.090
Why?
Telemedicine
1
2018
498
0.090
Why?
Lymphokines
2
2002
69
0.090
Why?
Drug Costs
1
2011
67
0.090
Why?
Liver Function Tests
1
2011
107
0.090
Why?
Retinopathy of Prematurity
1
2011
61
0.090
Why?
Age Factors
1
2018
2977
0.090
Why?
Glucose
1
2015
924
0.090
Why?
Refraction, Ocular
1
2013
312
0.090
Why?
Laser Therapy
1
2013
252
0.090
Why?
Florida
1
2010
79
0.080
Why?
Decision Making
1
2015
695
0.080
Why?
Acute Disease
2
2010
1185
0.080
Why?
Penicillins
1
2011
155
0.080
Why?
Prognosis
7
2024
5073
0.080
Why?
Signal Transduction
3
2021
4889
0.080
Why?
Neoplasms
2
2004
3012
0.080
Why?
Flucytosine
1
2009
17
0.080
Why?
Child
3
2024
25711
0.080
Why?
Cryptococcus neoformans
1
2009
23
0.080
Why?
Immunohistochemistry
6
2003
1760
0.080
Why?
Clinical Trials, Phase III as Topic
2
2021
77
0.080
Why?
In Situ Hybridization
4
2004
484
0.080
Why?
Intraoperative Complications
1
2010
175
0.080
Why?
Meningeal Carcinomatosis
1
2008
4
0.080
Why?
Preoperative Care
1
2011
371
0.080
Why?
Diagnostic Imaging
1
2011
312
0.080
Why?
Subarachnoid Space
1
2008
25
0.080
Why?
Mesencephalon
1
2008
38
0.070
Why?
Neoplasm Invasiveness
2
2008
664
0.070
Why?
Eye Enucleation
1
2008
54
0.070
Why?
Incidence
1
2016
3386
0.070
Why?
Keratoplasty, Penetrating
1
2008
54
0.070
Why?
Fatal Outcome
1
2008
372
0.070
Why?
Reproducibility of Results
3
2020
3062
0.070
Why?
Treatment Failure
1
2008
361
0.070
Why?
Blotting, Western
4
2003
1138
0.070
Why?
Carcinoma, Squamous Cell
3
2001
874
0.070
Why?
Case-Control Studies
2
2024
3632
0.070
Why?
Urinary Bladder Neoplasms
2
2002
553
0.060
Why?
Body Weights and Measures
1
2006
45
0.060
Why?
Capillaries
2
2017
69
0.060
Why?
Neurosurgical Procedures
1
2008
321
0.060
Why?
Head and Neck Neoplasms
2
2001
693
0.060
Why?
Hydrocephalus
1
2008
274
0.060
Why?
Pilot Projects
2
2020
1488
0.060
Why?
Transfection
3
2004
1090
0.060
Why?
Phenotype
3
2025
4527
0.060
Why?
Magnetic Resonance Imaging
2
2024
3840
0.060
Why?
Basic Helix-Loop-Helix Transcription Factors
3
2003
406
0.060
Why?
Immunoblotting
2
2004
317
0.060
Why?
Suspensions
1
2024
10
0.060
Why?
Search Engine
1
2023
7
0.050
Why?
Pandemics
2
2023
1191
0.050
Why?
Organic Chemicals
1
2023
60
0.050
Why?
Plasmids
2
2004
525
0.050
Why?
Vitreous Hemorrhage
1
2023
9
0.050
Why?
RNA, Messenger
4
2004
2898
0.050
Why?
Equivalence Trials as Topic
1
2023
14
0.050
Why?
Vascular Endothelial Growth Factor C
1
2023
10
0.050
Why?
Inflammation
2
2022
1601
0.050
Why?
DNA Mutational Analysis
1
2025
839
0.050
Why?
Nephrons
1
2002
21
0.050
Why?
Neurofibromin 2
1
2022
11
0.050
Why?
Indocyanine Green
2
2015
63
0.050
Why?
Adenocarcinoma, Clear Cell
1
2002
25
0.050
Why?
Syringes
1
2022
25
0.050
Why?
Cell Division
2
2001
773
0.050
Why?
Up-Regulation
2
2004
907
0.050
Why?
Photosensitizing Agents
1
2022
43
0.050
Why?
Data Interpretation, Statistical
1
2023
240
0.050
Why?
Pentosan Sulfuric Polyester
1
2021
1
0.050
Why?
Cell Adhesion Molecule-1
1
2021
1
0.050
Why?
Monocyte Chemoattractant Proteins
1
2021
9
0.050
Why?
Neoplasm Recurrence, Local
1
2008
1313
0.050
Why?
Canada
1
2022
343
0.050
Why?
Platelet Endothelial Cell Adhesion Molecule-1
1
2021
29
0.050
Why?
Urokinase-Type Plasminogen Activator
1
2021
39
0.050
Why?
Tissue Inhibitor of Metalloproteinase-1
1
2021
40
0.050
Why?
Sensitivity and Specificity
2
2019
2166
0.040
Why?
Pedigree
1
2025
1694
0.040
Why?
Genetic Association Studies
1
2025
843
0.040
Why?
Helix-Loop-Helix Motifs
1
2001
43
0.040
Why?
RNA
2
2004
601
0.040
Why?
Ribonucleases
1
2000
51
0.040
Why?
Oligonucleotide Array Sequence Analysis
2
2002
1069
0.040
Why?
Radiation-Sensitizing Agents
1
2000
27
0.040
Why?
Iatrogenic Disease
1
2021
136
0.040
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2008
1358
0.040
Why?
Machine Learning
1
2024
327
0.040
Why?
Extracellular Space
1
2001
90
0.040
Why?
Carcinoma, Ductal, Breast
1
2001
91
0.040
Why?
Antigens, Nuclear
1
2001
57
0.040
Why?
Multicenter Studies as Topic
1
2021
289
0.040
Why?
Organ Size
1
2022
468
0.040
Why?
Slit Lamp Microscopy
1
2020
5
0.040
Why?
Antibody Specificity
1
2001
206
0.040
Why?
Saccharomyces cerevisiae Proteins
1
2002
283
0.040
Why?
Nitroimidazoles
1
2000
44
0.040
Why?
Liver Neoplasms
1
2011
1407
0.040
Why?
Half-Life
1
2020
160
0.040
Why?
Observation
1
2020
45
0.040
Why?
Erythropoietin
1
2001
110
0.040
Why?
Trans-Activators
2
2001
827
0.040
Why?
Homeodomain Proteins
1
2003
585
0.040
Why?
Immunoglobulin Fab Fragments
1
2019
64
0.040
Why?
Protein Isoforms
1
2001
427
0.040
Why?
Genes, Reporter
1
2000
394
0.040
Why?
Breast
1
2001
219
0.040
Why?
Calcinosis
1
2001
194
0.040
Why?
Promoter Regions, Genetic
2
2000
1413
0.040
Why?
Repressor Proteins
1
2004
867
0.040
Why?
Medicare
1
2023
464
0.040
Why?
Genetic Therapy
1
2024
727
0.040
Why?
Protein Binding
2
2020
1831
0.040
Why?
Interleukin-6
1
2021
453
0.040
Why?
Cells
1
1999
25
0.040
Why?
Image Interpretation, Computer-Assisted
1
2020
235
0.040
Why?
Genotype
1
2025
2805
0.040
Why?
Gene Expression Regulation
4
2004
2661
0.040
Why?
Specialization
1
2019
82
0.040
Why?
Cell Cycle Proteins
1
2002
695
0.040
Why?
Research Design
1
2023
757
0.040
Why?
Expert Testimony
1
2018
37
0.040
Why?
Quality Improvement
1
2024
687
0.040
Why?
Anesthetics, Local
1
2019
91
0.040
Why?
Health Care Surveys
1
2019
292
0.040
Why?
Hemorrhage
1
2021
505
0.040
Why?
Carcinoma
1
2000
322
0.040
Why?
Caveolins
1
1997
15
0.040
Why?
Models, Genetic
1
2000
789
0.030
Why?
Multimodal Imaging
1
2018
129
0.030
Why?
European Union
1
2016
13
0.030
Why?
Infant
2
2011
13123
0.030
Why?
Emergency Medical Services
1
2021
415
0.030
Why?
Anticoagulants
1
2021
598
0.030
Why?
Tomography, X-Ray Computed
1
2024
2221
0.030
Why?
Gene Expression
1
2001
1615
0.030
Why?
Internet
1
2019
398
0.030
Why?
Enzyme-Linked Immunosorbent Assay
1
2018
866
0.030
Why?
Delivery of Health Care
1
2022
676
0.030
Why?
Drug Substitution
1
2015
22
0.030
Why?
Voriconazole
1
2014
35
0.030
Why?
Prosthesis Design
1
2017
710
0.030
Why?
COS Cells
2
2004
283
0.030
Why?
Logistic Models
1
2019
1907
0.030
Why?
Survival Analysis
3
2003
1599
0.030
Why?
Cell Transformation, Neoplastic
1
1997
645
0.030
Why?
Recombinant Proteins
1
1997
1439
0.030
Why?
Visual Fields
1
2014
138
0.030
Why?
Observer Variation
1
2014
313
0.030
Why?
Drug-Related Side Effects and Adverse Reactions
1
2016
282
0.030
Why?
Light Coagulation
1
2013
24
0.030
Why?
RNA, Neoplasm
2
2004
144
0.030
Why?
Nevus
1
2013
36
0.030
Why?
Skin Neoplasms
1
2000
906
0.030
Why?
Hyperthermia, Induced
1
2013
58
0.030
Why?
Immunoenzyme Techniques
2
2002
260
0.020
Why?
Hemangioma
1
2013
97
0.020
Why?
Child, Preschool
2
2022
14762
0.020
Why?
Mass Screening
1
2018
832
0.020
Why?
Retinoblastoma
1
2013
119
0.020
Why?
Models, Theoretical
1
2014
398
0.020
Why?
Retinal Neoplasms
1
2013
104
0.020
Why?
Radiation Injuries
1
2013
164
0.020
Why?
Neoplasms, Multiple Primary
1
2012
72
0.020
Why?
Enzyme Induction
2
2001
105
0.020
Why?
Microbial Sensitivity Tests
1
2014
828
0.020
Why?
Diabetes Mellitus, Type 1
1
2019
862
0.020
Why?
Prevalence
1
2016
2653
0.020
Why?
Coloring Agents
1
2009
81
0.020
Why?
Fluorescence
1
2009
103
0.020
Why?
Membrane Proteins
1
1997
1610
0.020
Why?
Response Elements
2
1999
106
0.020
Why?
Diabetes Mellitus, Type 2
1
2019
1403
0.020
Why?
Syndrome
1
2009
1148
0.020
Why?
Hypoxia-Inducible Factor-Proline Dioxygenases
1
2004
22
0.010
Why?
Procollagen-Proline Dioxygenase
1
2004
36
0.010
Why?
Immune Sera
1
2004
95
0.010
Why?
Mixed Function Oxygenases
1
2004
35
0.010
Why?
Immediate-Early Proteins
1
2004
60
0.010
Why?
Tissue Distribution
1
2004
404
0.010
Why?
Doxycycline
1
2004
121
0.010
Why?
Survival
1
2003
20
0.010
Why?
Microscopy, Fluorescence
1
2004
337
0.010
Why?
Animals
5
2004
36308
0.010
Why?
Apoptosis
2
2002
1933
0.010
Why?
Receptors, Antigen, B-Cell
1
2002
33
0.010
Why?
Glucose Transporter Type 1
1
2002
26
0.010
Why?
RNA Probes
1
2002
31
0.010
Why?
RNA Interference
1
2004
544
0.010
Why?
Isoenzymes
1
2003
232
0.010
Why?
Monosaccharide Transport Proteins
1
2002
43
0.010
Why?
In Situ Nick-End Labeling
1
2002
130
0.010
Why?
RNA, Small Interfering
1
2004
714
0.010
Why?
Down-Regulation
1
2004
715
0.010
Why?
Thymidine Phosphorylase
1
2001
13
0.010
Why?
Mucin-1
1
2001
37
0.010
Why?
Mice, Inbred BALB C
1
2004
1086
0.010
Why?
Fibroblast Growth Factor 2
1
2001
55
0.010
Why?
DNA Primers
1
2002
671
0.010
Why?
England
1
2001
72
0.010
Why?
Drug Therapy
1
2001
93
0.010
Why?
Protein Kinases
1
2002
342
0.010
Why?
Nephrectomy
1
2002
181
0.010
Why?
Radiotherapy
1
2001
151
0.010
Why?
Endothelium, Vascular
1
2003
520
0.010
Why?
Antigens, CD
1
2002
452
0.010
Why?
ErbB Receptors
1
2001
303
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2002
1326
0.010
Why?
Mice
3
2004
18845
0.010
Why?
Cobalt
1
1999
18
0.010
Why?
Iron Chelating Agents
1
1999
15
0.010
Why?
Multivariate Analysis
1
2003
1490
0.010
Why?
Disease-Free Survival
1
2001
973
0.010
Why?
Cell Line
1
2004
2843
0.010
Why?
Multienzyme Complexes
1
1999
88
0.010
Why?
Adaptor Proteins, Signal Transducing
1
2002
619
0.010
Why?
Cysteine Endopeptidases
1
1999
119
0.010
Why?
Transcription, Genetic
1
2004
1756
0.010
Why?
Infant, Newborn
1
2011
8572
0.010
Why?
Proteasome Endopeptidase Complex
1
1999
270
0.010
Why?
Receptor, ErbB-2
1
2001
560
0.010
Why?
Survival Rate
1
2003
2204
0.010
Why?
Genes, fos
1
1997
15
0.010
Why?
Mammals
1
1999
277
0.010
Why?
3T3 Cells
1
1997
123
0.010
Why?
Caveolin 1
1
1997
50
0.010
Why?
HeLa Cells
1
1999
827
0.010
Why?
Carrier Proteins
1
2002
1061
0.010
Why?
Genes, ras
1
1997
101
0.010
Why?
Neoplasm Staging
1
2001
1403
0.010
Why?
Drug Resistance, Neoplasm
1
2001
821
0.010
Why?
Predictive Value of Tests
1
2001
2307
0.010
Why?
Transcriptional Activation
1
1997
496
0.010
Why?
Lung
1
2003
1562
0.010
Why?
Adenocarcinoma
1
2001
1074
0.010
Why?
WYKOFF's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (522)
Explore
_
Co-Authors (4)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_